Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Raffa

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Peptides|March 1, 1989
Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activityR B Raffa
Life Sciences|May 19, 1998
Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor bindingR B Raffa
Journal of Clinical Pharmacy and Therapeutics|May 7, 2011
A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog')R B Raffa
Journal of Clinical Pharmacy and Therapeutics|May 10, 2013
Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment)R B Raffa
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
The M5 muscarinic receptor as possible target for treatment of drug abuseR B Raffa
Neuroscience Letters|June 30, 1986
Evidence for a role of conditioning in the development of tolerance to morphine-induced inhibition of gastrointestinal transit in ratsR B Raffa, F Porreca
Life Sciences|January 1, 1989
Thermodynamic analysis of the drug-receptor interactionR B Raffa, F Porreca
Journal of Clinical Pharmacy and Therapeutics|April 20, 2011
Multi-mechanistic analgesia for opioid-induced hyperalgesiaR B Raffa, J V Pergolizzi
NIDA Research Monograph|January 1, 1991
[D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick testR B Raffa, C D Connelly
Life Sciences|January 1, 1994
Opioid mu receptor subtypes (possibly mu 1 and mu 2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK miceR B Raffa, J J Schupsky
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Peptides|March 1, 1989
Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activityR B Raffa
Life Sciences|May 19, 1998
Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor bindingR B Raffa
Journal of Clinical Pharmacy and Therapeutics|May 7, 2011
A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog')R B Raffa
Journal of Clinical Pharmacy and Therapeutics|May 10, 2013
Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment)R B Raffa
Journal of Clinical Pharmacy and Therapeutics|February 24, 2010
The M5 muscarinic receptor as possible target for treatment of drug abuseR B Raffa
Neuroscience Letters|June 30, 1986
Evidence for a role of conditioning in the development of tolerance to morphine-induced inhibition of gastrointestinal transit in ratsR B Raffa, F Porreca
Life Sciences|January 1, 1989
Thermodynamic analysis of the drug-receptor interactionR B Raffa, F Porreca
Journal of Clinical Pharmacy and Therapeutics|April 20, 2011
Multi-mechanistic analgesia for opioid-induced hyperalgesiaR B Raffa, J V Pergolizzi
NIDA Research Monograph|January 1, 1991
[D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick testR B Raffa, C D Connelly
Life Sciences|January 1, 1994
Opioid mu receptor subtypes (possibly mu 1 and mu 2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK miceR B Raffa, J J Schupsky
Pageof 18